David R. Pelizzon
Director at OrthoPediatrics; Director at Alphatec Holdings. Based in Granby, Connecticut.
- Rank
- 1161st of 14,644
- Companies held
- 2
- Largest holding
- KIDS, 72.7% of total
- Latest SEC filing
- Sep 10, 2026
What the $141M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| OrthoPediatrics KIDS Common Stock | Through Squadron Capital LLC Reported jointly by 2 insiders; split evenly | 3,100,882 | $32.51 | $101M | 71.6% | Form 4, Sep 10, 2026 |
| Alphatec Holdings ATEC Common Stock | Through Squadron Capital LLC Reported jointly by 2 insiders; split evenly | 5,197,523 | $6.90 | $35.9M | 25.5% | Form 4, Jun 10, 2026 |
| Alphatec Holdings ATEC Common Stock | Directly | 378,839 | $6.90 | $2.6M | 1.9% | Form 4, Jun 10, 2026 |
| OrthoPediatrics KIDS Common Stock | Directly | 44,384 | $32.51 | $1.4M | 1.0% | Form 4, Sep 10, 2026 |
Share counts are the amounts David R. Pelizzon reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Sold | KIDS | 302,369 | $21.01 | $6.4M | View |
| Sep 2, 2026 | Sold | KIDS | 22,500 | $23.35 | $525K | View |
| Sep 1, 2026 | Sold | KIDS | 10,131 | $23.10 | $234K | View |
| Aug 28, 2026 | Sold | KIDS | 326,700 | $23.04 | $7.5M | View |
| Aug 26, 2026 | Sold | KIDS | 18,000 | $24.28 | $437K | View |
| Aug 25, 2026 | Sold | KIDS | 16,300 | $24.74 | $403K | View |
| Aug 24, 2026 | Sold | KIDS | 4,000 | $25.75 | $103K | View |
| Dec 16, 2025 | Sold | ATEC | 250,000 | $19.66 | $4.9M | View |
| Dec 9, 2025 | Sold | ATEC | 28,834 | $21.03 | $606K | View |
| Dec 8, 2025 | Sold | ATEC | 221,166 | $21.20 | $4.7M | View |
| Nov 24, 2025 | Sold | ATEC | 250,000 | $20.62 | $5.2M | View |
| Nov 12, 2025 | Sold | ATEC | 250,000 | $20.80 | $5.2M | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1158 | Kyle Wool Director, New America Acquisition I. New York, NY | $141M |
| 1159 | John Kristofer Galashan Director, Life Time Group Holdings. Los Angeles, CA | $141M |
| 1160 | Travis Murdoch CEO and President, Braveheart Bio. San Francisco, CA | $141M |
| 1161 | David R. Pelizzon Director, OrthoPediatrics. Granby, CT | $141M |
| 1162 | John L. Higgins Director, Ligand Pharmaceuticals. Minneapolis, MN | $141M |
| 1163 | Ramin Kamfar Director, Bluerock Private Real Estate Fund. New York, NY | $140M |
| 1164 | Kenneth S. Courtis Director, Alpha Metallurgical Resources. Bristol, TN | $140M |
Other OrthoPediatrics insiders
All KIDS insiders- Jennifer N. Pritzker$101M10% owner. #1068 overall
- David R. Bailey$13.6MPresident and CEO. #6975 overall
- Fred Hite$9.0MCOO and CFO. #9494 overall
- Mark C. Throdahl$6.6MDirector. #11947 overall
- Joseph W. Hauser$6.3MPres. Trauma & Def. Correction. #12289 overall
- Gregory A. Odle$6.1MPresident of Scoliosis. #12610 overall
Questions
How much stock does David R. Pelizzon own?
David R. Pelizzon holds $140,729,492 in listed stock based on SEC filings and current prices, mostly OrthoPediatrics (KIDS). That ranks 1161st on the Stock Rich List.
Is this David R. Pelizzon's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did David R. Pelizzon last buy or sell stock?
The most recent open-market trade on file is a sale of 302,369 KIDS shares on Sep 10, 2026 at $21.01.